LakeShore Biopharma Co., Ltd (LSB)
USD 1.19
(-4.8%)
USD 1.19
(-4.8%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 424.46 Million CNY | -14.87% |
| 2022 | 498.62 Million CNY | 31.02% |
| 2021 | 380.58 Million CNY | 7596492.14% |
| 2020 | 5010.00 CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 FY | 424.46 Million CNY | -14.87% |
| 2023 Q3 | 78.79 Million USD | -85.78% |
| 2023 Q2 | 554.19 Million CNY | 5.24% |
| 2023 Q1 | 526.61 Million CNY | 5.61% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q4 | 498.62 Million CNY | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q1 | - USD | -100.0% |
| 2020 Q3 | 5010.00 USD | 0.0% |
| 2020 Q4 | 40.01 Thousand USD | 698.6% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -1013.963% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -14679.41% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -7681.203% |
| Autolus Therapeutics plc | 52.96 Million USD | -701.376% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -41030.295% |
| Shattuck Labs, Inc. | 4.2 Million USD | -10001.491% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -117155.427% |
| CervoMed Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1595.011% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -1932.465% |
| Aptose Biosciences Inc. | 1 Million USD | -41934.276% |
| Precision BioSciences, Inc. | 31.26 Million USD | -1257.505% |
| Dyadic International, Inc. | 136.92 Thousand USD | -309888.859% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -359.213% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -268548.509% |
| Nektar Therapeutics | 230.4 Million USD | -84.229% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -2937.531% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -198247.965% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -7661.284% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -161909.406% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -85.007% |
| GRI Bio, Inc. | 14 Thousand USD | -3031790.321% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -3316.489% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -298818.764% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -5443.198% |
| IGM Biosciences, Inc. | 40.5 Million USD | -947.906% |
| INmune Bio, Inc. | 10.43 Million USD | -3966.922% |
| Opthea Limited | 200.62 Million USD | -111.567% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -719.825% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -230.508% |
| Verastem, Inc. | 41.55 Million USD | -921.403% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -7760.456% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -3632.542% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -4225.534% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -6785.071% |
| NextCure, Inc. | 6.6 Million USD | -6326.414% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -68141.575% |
| Organovo Holdings, Inc. | 1.39 Million USD | -30349.401% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Arvinas, Inc. | 3.4 Million USD | -12384.254% |
| Ovid Therapeutics Inc. | 46 Million USD | -822.715% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -1898.515% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -1310.228% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -401.802% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -1304.768% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -583.793% |
| Senti Biosciences, Inc. | 37.66 Million USD | -1026.917% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -261403.505% |
| Apollomics, Inc. | 4.66 Million USD | -9006.729% |
| PureTech Health plc | 25.51 Million USD | -1563.784% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -133379.448% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -3171.152% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -401.293% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 3.27 Million USD | -12852.842% |
| Beam Therapeutics Inc. | 173.17 Million USD | -145.11% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -307.426% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -1286.505% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -282.649% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -305.12% |
| Mesoblast Limited | 118.92 Million USD | -256.924% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -85.201% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -309.968% |
| MediWound Ltd. | 6.71 Million USD | -6224.909% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -318.67% |
| Fortress Biotech, Inc. | 88.59 Million USD | -379.123% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -13.578% |
| Achilles Therapeutics plc | 4.61 Million USD | -9097.5% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -98.407% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -2701.562% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -571.972% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -4413.661% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -1237.655% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 34.178% |
| FibroGen, Inc. | 170.45 Million USD | -149.019% |
| Celcuity Inc. | 37.44 Million USD | -1033.529% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -4574.206% |
| ContextLogic Inc. | 6 Million USD | -6974.411% |
| GH Research PLC | 343 Thousand USD | -123650.625% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -6371.484% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1147101.743% |
| ImmuCell Corporation | 11.96 Million USD | -3446.277% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -9918.047% |
| Amarin Corporation plc | 8.73 Million USD | -4758.242% |
| TG Therapeutics, Inc. | 110.79 Million USD | -283.108% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -7764.826% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -15135.63% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -841.727% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -29812.942% |
| Aptorum Group Limited | 3.36 Million USD | -12523.871% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -883.263% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 49.987% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -108181.245% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -268.552% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -94105.94% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -6046.317% |
| Ardelyx, Inc. | 55.98 Million USD | -658.216% |
| Ainos, Inc. | 5.96 Million USD | -7017.643% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -1479.051% |
| Prothena Corporation plc | 11.83 Million USD | -3486.52% |
| HilleVax, Inc. | 51.19 Million USD | -729.146% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1582.047% |
| Celularity Inc. | 65.41 Million USD | -548.86% |
| Rallybio Corporation | 392 Thousand USD | -108181.797% |
| Cue Biopharma, Inc. | 14.69 Million USD | -2788.497% |
| Omeros Corporation | 338.28 Million USD | -25.477% |
| Humacyte, Inc. | 58.1 Million USD | -630.501% |
| Immunocore Holdings plc | 84.03 Million USD | -405.123% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -22806.889% |
| Blueprint Medicines Corporation | 774.12 Million USD | 45.168% |
| IO Biotech, Inc. | 2.49 Million USD | -16919.432% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -731735.595% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -8358.841% |
| Summit Therapeutics Inc. | 106.09 Million USD | -300.065% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -284.625% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -586.636% |
| Pulmatrix, Inc. | 8.75 Million USD | -4747.7% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -6036.543% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -628.307% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -2964.727% |
| Acelyrin, Inc. | 1.19 Million USD | -35449.803% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -267.993% |
| Cytokinetics, Incorporated | 755.77 Million USD | 43.837% |
| Vor Biopharma Inc. | 35.66 Million USD | -1090.31% |
| Evogene Ltd. | 1.13 Million USD | -37199.178% |
| Replimune Group, Inc. | 75.86 Million USD | -459.47% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -34521.912% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1679.605% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -769345.563% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 75.603% |
| AEON Biopharma, Inc. | 278 Thousand USD | -152585.124% |
| BioLineRx Ltd. | 11.59 Million USD | -3562.019% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -491.119% |
| Atai Life Sciences N.V. | 16.47 Million USD | -2476.26% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -62783.651% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -19921.917% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -827.325% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -652922.531% |
| MediciNova, Inc. | 215.92 Thousand USD | -196478.756% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -16912.611% |
| MiMedx Group, Inc. | 48.09 Million USD | -782.481% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -33560.208% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -127.751% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -2.274% |
| Mereo BioPharma Group plc | 5.95 Million USD | -7031.462% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -25861.14% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -4533.388% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -1448.293% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Allakos Inc. | 41.46 Million USD | -923.67% |
| scPharmaceuticals Inc. | 40.26 Million USD | -954.073% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -3822.601% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -281002.414% |
| NLS Pharmaceutics AG | 1.63 Million USD | -25881.067% |
| Precigen, Inc. | 7.09 Million USD | -5880.902% |
| XOMA Corporation | 124.45 Million USD | -241.072% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -2141.93% |
| Incyte Corporation | 38.28 Million USD | -1008.639% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -141052.273% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -883.308% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -3710.959% |
| Seer, Inc. | 28.25 Million USD | -1402.051% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -77.874% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1529.861% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -121523.107% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -129907.273% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Novavax, Inc. | 280.63 Million USD | -51.251% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -258771.996% |
| UroGen Pharma Ltd. | 100.21 Million USD | -323.558% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -132.266% |
| Entera Bio Ltd. | 390 Thousand USD | -108737.088% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -139068.736% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -6110.163% |
| Chimerix, Inc. | 2.14 Million USD | -19697.791% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -43524.321% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -205.304% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -1093.817% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 92.677% |
| AnaptysBio, Inc. | 17.81 Million USD | -2282.759% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 47 Thousand USD | -903016.266% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -17461.632% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -3094.826% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -32570.83% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1988024.801% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -281835.15% |
| AbCellera Biologics Inc. | 77.38 Million USD | -448.546% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -8014.407% |
| NLS Pharmaceutics AG | 1.63 Million USD | -25881.067% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 5.31 Million USD | -7881.442% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -75026.486% |
| Bicycle Therapeutics plc | 44.95 Million USD | -844.178% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -382.653% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -37101.108% |
| Erasca, Inc. | 55.85 Million USD | -659.886% |
| bluebird bio, Inc. | 330.32 Million USD | -28.499% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 62.565% |
| DBV Technologies S.A. | 14.38 Million USD | -2851.566% |
| Fortress Biotech, Inc. | 88.59 Million USD | -379.123% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -4208.411% |
| CorMedix Inc. | 667.63 Thousand USD | -63477.636% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -4.862% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -6737.382% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -25060.916% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -9109.474% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -16598.058% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -3774.62% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -2151.444% |
| Onconetix, Inc. | 9.88 Million USD | -4193.692% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -3013.509% |
| Adagene Inc. | 22.3 Million USD | -1802.843% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -101.99% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -52406.63% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 30.526% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -466.656% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -1991.68% |
| SciSparc Ltd. | 76 Thousand USD | -558406.112% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -417.534% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -128916.609% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -7557.67% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -25913.246% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -106.135% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 84.177% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -673653.405% |
| 2seventy bio, Inc. | 256.67 Million USD | -65.372% |
| ADMA Biologics, Inc. | 141.41 Million USD | -200.149% |
| Clene Inc. | 32.16 Million USD | -1219.812% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -7463.311% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -19237.797% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -737.671% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -88101.362% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -119.711% |
| Absci Corporation | 15.95 Million USD | -2560.053% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 84.296% |
| Surrozen, Inc. | 3.37 Million USD | -12461.842% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -1444.35% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1629.544% |
| Cingulate Inc. | 3.13 Million USD | -13439.115% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -1035179.622% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -84639.889% |
| Jaguar Health, Inc. | 35.86 Million USD | -1083.672% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -70292.147% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -642.006% |
| Kronos Bio, Inc. | 28.27 Million USD | -1401.361% |
| Innoviva, Inc. | 449.07 Million USD | 5.48% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -1999.336% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -522.109% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -4903604.309% |
| Soligenix, Inc. | 3.49 Million USD | -12046.437% |
| AlloVir, Inc. | 27.42 Million USD | -1447.503% |
| Century Therapeutics, Inc. | 48.17 Million USD | -781.162% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -4056.121% |
| Kura Oncology, Inc. | 17.2 Million USD | -2367.818% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -19642.542% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -914.422% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -46750.402% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -136.302% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -7085.719% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -519567.783% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -51235.517% |
| HCW Biologics Inc. | 6.45 Million USD | -6479.035% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -498.04% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -633.454% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 11.725% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -180930.765% |
| Histogen Inc. | 4.62 Million USD | -9083.571% |
| Surrozen, Inc. | 3.37 Million USD | -12461.842% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -110726.278% |
| Kodiak Sciences Inc. | 181.63 Million USD | -133.695% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -11378.638% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -202973.699% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -465.681% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -10775.343% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 70.798% |
| Turnstone Biologics Corp. | 3.21 Million USD | -13106.741% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -171748.034% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -334.871% |
| Exelixis, Inc. | 189.94 Million USD | -123.468% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -821.968% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -1221.579% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -42992.857% |
| Alkermes plc | 290.73 Million USD | -46.0% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -15135.63% |
| Arcellx, Inc. | 97.62 Million USD | -334.791% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -528314.308% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -868458.717% |
| Avid Bioservices, Inc. | 207.83 Million USD | -104.233% |
| Insmed Incorporated | 1.2 Billion USD | 64.745% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -19651.728% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -1500.968% |
| Moolec Science SA | 2.64 Million USD | -15946.059% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -1390.029% |
| Geron Corporation | 85.89 Million USD | -394.144% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -6623.66% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -832.684% |
| Royalty Pharma plc | 6.13 Billion USD | 93.082% |
| OmniAb, Inc. | 25.56 Million USD | -1560.595% |
| Alector, Inc. | 38.91 Million USD | -990.664% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -17571.301% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -1154.699% |
| Humacyte, Inc. | 58.1 Million USD | -630.501% |
| Structure Therapeutics Inc. | 5.45 Million USD | -7684.056% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 11.28% |
| 89bio, Inc. | 27.1 Million USD | -1465.828% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 19.55 Million USD | -2070.398% |
| Immunic, Inc. | 1.33 Million USD | -31718.939% |
| Veracyte, Inc. | 12.63 Million USD | -3260.765% |
| Genelux Corporation | 2.51 Million USD | -16750.522% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -31623.815% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -208061.72% |
| Immunovant, Inc. | 138 Thousand USD | -307483.076% |
| Vericel Corporation | 88.14 Million USD | -381.564% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 74.704% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -5701.075% |
| XBiotech Inc. | - USD | -Infinity% |
| Agenus Inc. | 350.24 Million USD | -21.19% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -397000.453% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -519567.783% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -838.334% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -780.103% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -208995.884% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -41214.529% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -1954.424% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -25578.442% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -33587.67% |
| United Therapeutics Corporation | 700 Million USD | 39.362% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -2990351.212% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -420162.025% |
| Pharming Group N.V. | 171.54 Million USD | -147.436% |
| XOMA Corporation | 124.45 Million USD | -241.072% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -77.142% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3097.233% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -1889.896% |
| uniQure N.V. | 138.4 Million USD | -206.674% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -3604.85% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -245719.928% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -2422.072% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -396.897% |
| Pluri Inc. | 29.61 Million USD | -1333.421% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| MeiraGTx Holdings plc | 89.26 Million USD | -375.516% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -8603.396% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -307.763% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 4.627% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -146447.524% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3097.233% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -1245.456% |
| Nutriband Inc. | 241.28 Thousand USD | -175818.372% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -7664.124% |
| Compugen Ltd. | 1.35 Million USD | -31318.553% |
| Roivant Sciences Ltd. | 499.74 Million USD | 15.064% |
| ProKidney Corp. | 4.41 Million USD | -9518.505% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -201556.45% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -990.608% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -17218.047% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -892.528% |
| Benitec Biopharma Inc. | 284 Thousand USD | -149359.382% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Biomea Fusion, Inc. | 10.29 Million USD | -4022.617% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -11723.528% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -2793.222% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -3362.756% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -401.998% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -3294.088% |
| Imunon, Inc. | 1.62 Million USD | -26025.499% |
| BioAtla, Inc. | 2.46 Million USD | -17154.66% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -346.237% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -7553.528% |
| Zura Bio Limited | - USD | -Infinity% |
| aTyr Pharma, Inc. | 15.09 Million USD | -2711.955% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -262.193% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -1916.651% |
| Galecto, Inc. | 249 Thousand USD | -170367.729% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -25913.246% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 71.688% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -300.197% |
| PolyPid Ltd. | 11.77 Million USD | -3503.571% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -364.109% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 83.43 Million USD | -408.743% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -34572.082% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -258771.996% |
| Instil Bio, Inc. | 86.05 Million USD | -393.254% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -33560.208% |
| OncoCyte Corporation | 2.86 Million USD | -14694.864% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1308.45% |
| Purple Biotech Ltd. | 351 Thousand USD | -120830.098% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -13336.678% |
| MacroGenics, Inc. | 33.97 Million USD | -1149.491% |
| Verona Pharma plc | 51.32 Million USD | -726.949% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -20768.479% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -4241.017% |
| Aditxt, Inc. | 18.21 Million USD | -2229.921% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -1487.496% |
| Curis, Inc. | 2.79 Million USD | -15092.006% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -19767.764% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -2436.995% |
| BeiGene, Ltd. | 930.18 Million USD | 54.368% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -16865.014% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -10052.228% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -9040.066% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -600.68% |
| Adicet Bio, Inc. | 20.92 Million USD | -1928.602% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -2673.735% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 97.89 Million USD | -333.596% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1577.859% |
| Invivyd, Inc. | 2.16 Million USD | -19505.757% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -693.896% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -12045790.15% |
| Moolec Science SA | 2.64 Million USD | -15946.059% |
| Clearside Biomedical, Inc. | 43 Million USD | -887.104% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -89260.978% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -2368.248% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -240.826% |
| Evaxion Biotech A/S | 10.86 Million USD | -3805.034% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -409.018% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -6434.246% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -1472.674% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -91182.719% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -5943.062% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -11833.22% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -27196.762% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -33587.67% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -2838.692% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -720.57% |
| ImmunityBio, Inc. | 883.67 Million USD | 51.966% |
| Korro Bio, Inc. | 33.2 Million USD | -1178.238% |
| Kineta, Inc. | 1.31 Million USD | -32129.662% |
| BioVie Inc. | 6.11 Million USD | -6845.403% |
| Codexis, Inc. | 22.36 Million USD | -1797.982% |
| Celularity Inc. | 65.41 Million USD | -548.86% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -189139.699% |
| Cibus, Inc. | 24.62 Million USD | -1623.994% |
| Annexon, Inc. | 31.35 Million USD | -1253.738% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -18024.024% |
| Eyenovia, Inc. | 16.1 Million USD | -2535.156% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -280.72% |
| NeurAxis, Inc. | 224.26 Thousand USD | -189173.453% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -13583.58% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -24393.055% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -368186.259% |
| Notable Labs, Ltd. | 2.04 Million USD | -20615.698% |
| IN8bio, Inc. | 4.89 Million USD | -8574.937% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -106016.161% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -690.319% |
| Lumos Pharma, Inc. | 6.58 Million USD | -6345.932% |
| Liquidia Corporation | 3.5 Million USD | -12017.175% |
| Mustang Bio, Inc. | 2.49 Million USD | -16892.18% |
| Quantum-Si incorporated | 15.3 Million USD | -2673.735% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -4767.156% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -4241.017% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -154814.104% |
| 180 Life Sciences Corp. | 1.32 Million USD | -32054.732% |
| Vaxcyte, Inc. | 29.22 Million USD | -1352.452% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -3793.1% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -2030.74% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -2385.138% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -27196.762% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -105226.215% |
| PepGen Inc. | 20.1 Million USD | -2011.344% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -73848.544% |
| Solid Biosciences Inc. | 26.26 Million USD | -1516.085% |
| Palisade Bio, Inc. | 369 Thousand USD | -114931.069% |
| Nutriband Inc. | 241.28 Thousand USD | -175818.372% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -42992.857% |
| Immuneering Corporation | 4.46 Million USD | -9410.835% |
| Belite Bio, Inc | 886 Thousand USD | -47807.973% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -51287.972% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -102180.637% |
| Altimmune, Inc. | 671 Thousand USD | -63158.516% |
| Peak Bio, Inc. | 10.72 Million USD | -3858.891% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -4574.206% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -24196.774% |
| Neurogene Inc. | 16.25 Million USD | -2511.287% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -37.75% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -1387.21% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| argenx SE | 20 Million USD | -2022.323% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -2030.74% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -72458.059% |
| Immunome, Inc. | 1.65 Million USD | -25625.13% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 3.05 Million USD | -13816.874% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -2883.305% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -126605.864% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -459.522% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -594.625% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -1305.082% |
| Athira Pharma, Inc. | 1.58 Million USD | -26680.104% |
| XOMA Corporation | 124.45 Million USD | -241.072% |
| Merus N.V. | 12.16 Million USD | -3390.089% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -2972.714% |
| Rezolute, Inc. | 2.22 Million USD | -18951.375% |
| Clene Inc. | 32.16 Million USD | -1219.812% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -242377.79% |
| BeyondSpring Inc. | 3.99 Million USD | -10524.897% |
| Synlogic, Inc. | 17.27 Million USD | -2357.104% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -32551.127% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1212656.129% |
| Peak Bio, Inc. | 10.72 Million USD | -3858.891% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -717.489% |
| Krystal Biotech, Inc. | 8.09 Million USD | -5144.189% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -139.789% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -5914.803% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -310649.114% |
| MannKind Corporation | 382.37 Million USD | -11.006% |
| Ikena Oncology, Inc. | 10.73 Million USD | -3852.921% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -103681.087% |
| Gossamer Bio, Inc. | 212.46 Million USD | -99.782% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -243845.198% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -4533.388% |
| Legend Biotech Corporation | 328.67 Million USD | -29.145% |
| Mural Oncology plc | 15 Million USD | -2728.067% |
| Disc Medicine, Inc. | 2.1 Million USD | -20102.982% |
| Champions Oncology, Inc. | 7.43 Million USD | -5612.849% |
| REGENXBIO Inc. | 89.29 Million USD | -375.378% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -49562.587% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -76659.215% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -7740.13% |
| Vaxart, Inc. | 26.51 Million USD | -1500.908% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -2610.959% |
| Cellectis S.A. | 92.85 Million USD | -357.136% |
| Longeveron Inc. | 2.04 Million USD | -20696.896% |
| Repare Therapeutics Inc. | 3.41 Million USD | -12347.644% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 69.612% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -811.025% |
| Revolution Medicines, Inc. | 87.94 Million USD | -382.653% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -245255.286% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -10637.785% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -133800.519% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -242451.226% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 47.493% |
| Denali Therapeutics Inc. | 52.24 Million USD | -712.512% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -2846.553% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -30792.623% |
| Cingulate Inc. | 3.13 Million USD | -13439.115% |
| Passage Bio, Inc. | 26.29 Million USD | -1514.302% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -6268.562% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -103935.452% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -47379.267% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -1964.416% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -17217.164% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -13491.567% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -52238.427% |
| OmniAb, Inc. | 25.56 Million USD | -1560.595% |
| Anew Medical, Inc. | 1.6 Million USD | -26346.395% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1334.833% |
| Lipocine Inc. | 17.16 Thousand USD | -2472605.61% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -3547.23% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -1125.784% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -7085.719% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -642.422% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -208995.884% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -8118.096% |
| Ocugen, Inc. | 6.94 Million USD | -6015.324% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -2904.209% |
| Q32 Bio Inc. | 1.31 Million USD | -32105.208% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -63064.382% |
| Alumis Inc. Common Stock | 32.58 Million USD | -1202.838% |
| Equillium, Inc. | 824 Thousand USD | -51412.7% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -4575.236% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -141009.102% |
| Dominari Holdings Inc. | 3.02 Million USD | -13917.987% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -449130.735% |
| vTv Therapeutics Inc. | 529 Thousand USD | -80139.063% |
| Bio-Techne Corporation | 419.53 Million USD | -1.174% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -489.567% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -119.287% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -2413.41% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -1764.795% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -6906.68% |
| Nkarta, Inc. | 88.33 Million USD | -380.495% |
| BioCardia, Inc. | 1.31 Million USD | -32178.68% |
| Iterum Therapeutics plc | 19.5 Million USD | -2075.738% |